Log in to save to my catalogue

Durability of lopinavir/ritonavir dual‐therapies in individuals with viral load <50 copies/mL in the...

Durability of lopinavir/ritonavir dual‐therapies in individuals with viral load <50 copies/mL in the...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4225267

Durability of lopinavir/ritonavir dual‐therapies in individuals with viral load <50 copies/mL in the observational setting

About this item

Full title

Durability of lopinavir/ritonavir dual‐therapies in individuals with viral load <50 copies/mL in the observational setting

Publisher

Switzerland: International AIDS Society

Journal title

Journal of the International AIDS Society, 2014-11, Vol.17 (4S3), p.19799-n/a

Language

English

Formats

Publication information

Publisher

Switzerland: International AIDS Society

More information

Scope and Contents

Contents

Introduction
We aimed at evaluating the efficacy and durability of a lopinavir/ritonavir‐based dual regimen (LPV/r‐DR) in virologically controlled HIV‐infected individuals in current clinical practice.
Methods
Patients who have initiated for the first time a LPV/r‐DR with HIV‐RNA<50 copies/mL were included in this observational study. The...

Alternative Titles

Full title

Durability of lopinavir/ritonavir dual‐therapies in individuals with viral load <50 copies/mL in the observational setting

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4225267

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4225267

Other Identifiers

ISSN

1758-2652

E-ISSN

1758-2652

DOI

10.7448/IAS.17.4.19799

How to access this item